Skip to main content
SpringerLink
Log in

[18F]mFBG PET/CT imaging outperforms MRI and [68 Ga]Ga-DOTA-TOC PET/CT in identifying recurrence pheochromocytoma

  • Image of the Month
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data Availability

Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

References

  1. Taïeb D, Hicks RJ, Hindié E, Guillet BA, Avram A, Ghedini P, et al. European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2112–2137. https://doi.org/10.1007/s00259-019-04398-1.

  2. Han S, Suh CH, Woo S, Kim YJ, Lee JJ. Performance of 68Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET in detection of pheochromocytoma and paraganglioma: a systematic review and metaanalysis. J Nucl Med. 2019Mar;60(3):369–76. https://doi.org/10.2967/jnumed.118.211706.

    Article  CAS  PubMed  Google Scholar 

  3. Treglia G, Cocciolillo F, de Waure C, Di Nardo F, Gualano MR, Castaldi P, et al. Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis. Eur J Nucl Med Mol Imaging. 2012Jul;39(7):1144–53. https://doi.org/10.1007/s00259-012-2087-y.

    Article  PubMed  Google Scholar 

  4. Kroiss AS. Current status of functional imaging in neuroblastoma, pheochromocytoma, and paraganglioma disease. Wien Med Wochenschr. 2019 Feb;169(1–2):25–32. English. doi: https://doi.org/10.1007/s10354-018-0658-7

  5. Wang P, Li T, Cui Y, Zhuang H, Li F, Tong A, Jing H. 18F-MFBG PET/CT is an effective alternative of 68Ga-DOTATATE PET/CT in the evaluation of metastatic pheochromocytoma and paraganglioma. Clin Nucl Med. 2022 Oct 17. https://doi.org/10.1097/RLU.0000000000004447

Download references

Funding

Open Access funding provided by Utrecht University.

Author information

Authors and Affiliations

  1. Department of Surgical Oncology and Endocrine Surgery, University Medical Center Utrecht, Utrecht, the Netherlands

    Diederik P. D. Suurd & Menno R. Vriens

  2. Department of Nuclear Medicine and Radiology, University Medical Center Utrecht, Room Q 01.4.309, Heidelberglaan 100, Utrecht, 3584 CX, the Netherlands

    Alex J. Poot & Bart de Keizer

  3. Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, the Netherlands

    Rachel S. van Leeuwaarde

  4. Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands

    Albert D. Windhorst

Authors
  1. Diederik P. D. Suurd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alex J. Poot
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rachel S. van Leeuwaarde
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Albert D. Windhorst
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Menno R. Vriens
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bart de Keizer
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors approved the contents of the manuscript and its submission. The manuscript is not under review by any other journal.

Corresponding author

Correspondence to Bart de Keizer.

Ethics declarations

Ethics approval

The submitted work does not contain any studies with human participants performed by any of the authors.

Consent to participate

Informed consent and consent to publish were obtained from the individual patient for the data and images included in this work.

Consent for publication

Informed consent and consent to publish were obtained from the individual patient for the data and images included in this work.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Image of the month.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suurd, D.P.D., Poot, A.J., van Leeuwaarde, R.S. et al. [18F]mFBG PET/CT imaging outperforms MRI and [68 Ga]Ga-DOTA-TOC PET/CT in identifying recurrence pheochromocytoma. Eur J Nucl Med Mol Imaging 50, 1538–1540 (2023). https://doi.org/10.1007/s00259-022-06064-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-022-06064-5

Search

Navigation